The inaugural Crohn’s & Colitis Congress™ (Jan. 18-20, 2018, Las Vegas, Nevada) gathered more than 1,250 inflammatory bowel disease (IBD) health care professionals and featured more than 250 abstracts — with the goal of advancing research and transforming the care of IBD patients.
The Crohn’s & Colitis Congress is a new partnership between the Crohn’s & Colitis Foundation and AGA. Both organizations are proud of the success of the inaugural meeting and would like to thank all faculty and attendees. If you are involved in the research or care of IBD patients, save the date for the 2019 meeting: Feb. 7-9 in Las Vegas.
Here’s a glimpse of the science presented at the meeting. Edward V. Loftus Jr., MD, AGAF, an IBD expert and presenter at the Congress, took over AGA’s Twitter handle during the meeting to take us on a tour of the poster hall, selecting six noteworthy studies to share. You can review all abstracts presented at the Crohn’s & Colitis Congress in AGA’s journal Gastroenterology.
.@EdwardLoftus2 here sharing some top posters from #CCCongress. 1st up is a from Korea—ratios of week 2 to week 0 albumin and CRP associated with outcomes (colectomy, clinical response) pic.twitter.com/z2cR91Jbto
— AGA (@AmerGastroAssn) January 19, 2018
Vedolizumab Trough Levels and Antibodies in Inflammatory Bowel Disease: Updated Initial Experience
Our poster on vedolizumab trough levels. They were inversely correlated with CRP; however we didn’t see association between levels and mucosal healing @Badr_AlBawardy #CCCongress – @EdwardLoftus2 pic.twitter.com/6T6vR71Svd
— AGA (@AmerGastroAssn) January 19, 2018
In Olmsted County we found that baseline BMI was a protective factor in #Crohns and risk factor for UC in terms of bowel resection #obesity @amlynn087 #CCCongress – @EdwardLoftus2 pic.twitter.com/ZFBe5pTHcP
— AGA (@AmerGastroAssn) January 19, 2018
Dr Sid Singh examined individual patient data on BMI in 6 infliximab trials and couldn’t show relationship between BMI and IFX response #CCCongress – @EdwardLoftus2 pic.twitter.com/xhHKWQZavU
— AGA (@AmerGastroAssn) January 19, 2018
Opioid Dependence is on the Rise Among IBD Hospitalizations
.@ShirleyCoMekMD examined Nationwide Inpatient Sample to show that opioid use disorder related diagnoses are occurring more frequently with #IBD hospitalizations #CCCongress – @EdwardLoftus2 pic.twitter.com/7MDjJaM3fX
— AGA (@AmerGastroAssn) January 19, 2018
Final comments from the poster hall – a low red and processed meat diet did not reduce rate of #Crohns flares; however subject adherence to diet was low! (No bacon 🙁 ) #CCCongress – @EdwardLoftus2 pic.twitter.com/xYbre9dWAH
— AGA (@AmerGastroAssn) January 19, 2018